The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s fetal bovine serum market report forecasts the fetal bovine serum market size to grow to $1.4 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Fetal Bovine Serum Market Report 2023 – https://www.thebusinessresearchcompany.com/report/fetal-bovine-serum-global-market-report

Fetal Bovine Serum Market Size Forecast
The global fetal bovine serum market is expected to grow from $1010 million in 2022 to $1.06 billion in 2023 at a compound annual growth rate (CAGR) of 5.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The fetal bovine serum market size is expected to grow to $1.4 billion in 2027 at a CAGR of 7.4%.

North America held the largest fetal bovine serum market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Fetal Bovine Serum Market Driver ­– Increase In Demand For Biopharmaceuticals
A biopharmaceutical is a medicinal product that is derived from biological sources such as animals, humans, and microorganisms using biotechnology. Fetal bovine serum (FBS) is the most widely used substitute for animal cell culture media. Pharmaceutical firms, diagnostic laboratories, and researchers rely heavily on FBS for much of their cell culture requirements in biologics research. The global biologics market is expected to increase from $253.4 billion in 2020 to $420.5 billion by 2025. Therefore, the rising demand for biopharmaceuticals propels the growth of the fetal bovine serum market.

Request for A Sample Of The Global Fetal Bovine Serum Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4109&type=smp

Key Fetal Bovine Serum Market Trend – Increasing Collaborations Between Companies And Research Intuitions
Major companies are collaborating for increasing production capabilities, expanding market share and developing new products. For instance, US based GE Healthcare collaborated with New Zealand based Oritain for developing an independent test that can confirm the country of origin of fetal bovine serum (FBS) which would help biomanufacturing entities as FBS used in different countries pose different risk levels for virus contamination.

Fetal Bovine Serum Market Segment
1) By Product: Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products
2) By Application: Drug Discovery, Cell Culture Media, In Vitro Fertilization, Human and Animal Vaccine Production, Diagnostics, Other Applications
3) By End-User: Research and Academic Institutes, Biotechnology and Pharmaceutical Industry, Other End-Users

Fetal Bovine Serum Market Major Players and Strategies
Major players in the fetal bovine serum market are Sartorius AG, GE Healthcare, PAN- Biotech, Thermo Fisher Scientific Inc., Biowest, Bio-Techne, Rocky Mountain Biologicals Inc., Merck KGaA, TCS Biosciences Ltd., Bovogen Biologicals Pty Ltd., Tissue Culture Biologicals, Atlanta Biologicals Inc., Atlas Biologicals, Acess Biologicals, Animal Technologies Inc., Nucleus Biologics, Corning Incorporated, J R Scientific Inc., Cytiva, Axil Scientific Pte Ltd., and Moregate Biotech.

The Fetal Bovine Serum Global Market Report 2023 covers regional data on fetal bovine serum market size, fetal bovine serum market trends and drivers, opportunities, strategies, and fetal bovine serum market competitor analysis. The countries covered in the fetal bovine serum market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Fetal bovine serum refers to a typical element of animal cell culture media that is utilised to support the growth of eukaryotic cells cultured in vitro. It is obtained by harvesting bovine foetuses from pregnant cows who were about to be slaughtered. FBS is frequently obtained with a cardiac puncture without the use of any type of anaesthesia.

View More Reports Related To The Fetal Bovine Serum Market –
Fetal And Neonatal Monitoring Devices Global Market Report 2023
Fertility Drugs Global Market Report 2023
Fertility Treatments Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: